BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1157924)

  • 1. [Synthesis and antibacterial activity in vitro of some penicillins containing the phenylcyclohexanie residue].
    Cantarelli G; Carissimi M; Ravenna F; Riva G
    Farmaco Sci; 1975 Sep; 30(9):761-72. PubMed ID: 1157924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity in vitro of cyclacillin (author's transl).
    Oliva B; Piccolomini R; Nicoletti M
    Antibiotica; 1973; 11(3-4):105-10. PubMed ID: 4219567
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microbiological study with cyclacillin].
    Ravagnan G; Casalino M; Favalli C
    Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1427-32. PubMed ID: 1024550
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclacillin: microbiological and pharmacological properties and use in chemotherapy of infection - a critical appraisal.
    Warren GH
    Chemotherapy; 1976; 22(3-4):154-82. PubMed ID: 773605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclacillin: in vitro activity against aerobic and anaerobic bacteria.
    Thadepalli H; Roy I; Bach V
    Chemotherapy; 1979; 25(5):303-7. PubMed ID: 383419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and in vitro evaluation of cyclacillin: assessment as potential single-dose therapy for treatment of Neisseria gonorrhoeae infection.
    Wagner KF; Blair AD; Counts GW; Holmes KK
    Antimicrob Agents Chemother; 1980 Jan; 17(1):89-91. PubMed ID: 6766294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclacillin and ampicillin on the gut flora of mice.
    Schaedler RW; Warren GH
    Chemotherapy; 1980; 26(4):289-96. PubMed ID: 7389426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative experimental study of cyclacillin and ampicillin].
    Rudzit EA; Iakovlev VP; Zinchenko TA; Kulikova DA; Lisitsa LI
    Antibiotiki; 1979 May; 24(5):331-6. PubMed ID: 375825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels and antibacterial activity of sera in patients treated with cyclacillin.
    Yourassowsky E; Schoutens E; Vanderlinden MP; Butzler JP; Sternon J
    Int J Clin Pharmacol; 1974 Mar; 9(2):120-4. PubMed ID: 4151243
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibacterial activity in vitro and in vivo in animals of a combination of 2 semisynthetic penicillins: dicloxacillin and ethacillin].
    Varone GL; Catalano G; Abbate GF; Fici F
    G Mal Infett Parassit; 1972 Apr; 24(4):231-42. PubMed ID: 5050303
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased phagocytosis of Escherichia coli pretreated with subinhibitory concentrations of cyclacillin or ampicillin.
    Friedman H; Warren GH
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):301-5. PubMed ID: 7038695
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclacillin-induced potentiation of Escherichia coli immunogenicity in vivo and in vitro.
    Friedman H; Warren GH
    Chemotherapy; 1977; 23(5):324-36. PubMed ID: 332464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the antibacterial action in vitro of a combination of penicillins and other antibiotics on 127 strains isolated in an oncological institute].
    Buogo A; Zanuso G; Cattaneo P
    Atti Accad Med Lomb; 1973; 28(1-4):63-8. PubMed ID: 4807501
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-mediated bacteriolysis: enhanced killing of cyclacillin-treated bacteria.
    Friedman H; Warren GH
    Proc Soc Exp Biol Med; 1976 Nov; 153(2):301-4. PubMed ID: 792892
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis and antibacterial activity of benzoylaminoacyl-penicillins and related compounds with and without acylated catechol substituents].
    Heinisch L; Ulbricht H; Willitzer H; Hanschke KG; Tresselt D; Möllmann U; Eckardt K; Haupt I
    Arzneimittelforschung; 1992 May; 42(5):668-73. PubMed ID: 1530682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimicrobial activity of a dihydroampicillin and a dihydrocephalexin.
    Hashem AI; Shaban ME; Abdel-Aziz R; Abdel-Nasser G
    Arch Pharm (Weinheim); 1998 Sep; 331(9):294-6. PubMed ID: 9793485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclacillin (cyclapen)--another new penicillin.
    Med Lett Drugs Ther; 1980 Feb; 22(3):13-4. PubMed ID: 6986544
    [No Abstract]   [Full Text] [Related]  

  • 18. [General characteristics of polysynthetic penicillins].
    Doĭl FP
    Antibiotiki; 1971 Oct; 16(10):870-7. PubMed ID: 5003054
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ampicillin and combination penicillins in clinical medicine (antibacterial effects)].
    Metz H
    Munch Med Wochenschr; 1972 Sep; 114(35):1515-9. PubMed ID: 4628080
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial activity and pharmacological distribution of Wy-4508, an aminoalicyclic penicillin.
    Roseman SB; Weber LS; Owen G; Warren GH
    Antimicrob Agents Chemother (Bethesda); 1967; 7():590-6. PubMed ID: 5596195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.